viernes, 15 de noviembre de 2024

Nivolumab Appears to Boost Cure Rate in Advanced Hodgkin Lymphoma

https://www.cancer.gov/news-events/cancer-currents-blog/2024/hodgkin-lymphoma-nivolumab-avd-first-line?cid=eb_govdel

No hay comentarios:

Publicar un comentario